Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shamim

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 1, 2020
Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential TremorStuart H Isaacson, Elizabeth Peckham, Winona Tse, et al.
Rheumatology (Oxford, England)|April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS projectAnushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Journal of Parkinson'S Disease|May 7, 2026
Practical approaches to inclusive recruitment practices in Parkinson's disease researchLana M Chahine, Naomi Louie, Elizabeth Disbrow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
BMC Neurology|October 21, 2024
The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocolLana M Chahine, Naomi Louie, J Solle, et al.
The American Journal of Clinical Nutrition|September 30, 2021
Small-quantity lipid-based nutrient supplements for children age 6-24 months: a systematic review and individual participant data meta-analysis of effects on developmental outcomes and effect modifiersElizabeth L Prado, Charles D Arnold, K Ryan Wessells, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed PopulationsMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
The Lancet. Neurology|August 26, 2023
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association studyMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populationsFulya Akçimen, Kimberly Paquette, Peter Wild Crea, et al.
Brain : a Journal of Neurology|October 8, 2025
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populationsFulya Akçimen, Kimberly Paquette, Peter Wild Crea, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 1, 2020
Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential TremorStuart H Isaacson, Elizabeth Peckham, Winona Tse, et al.
Rheumatology (Oxford, England)|April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS projectAnushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Journal of Parkinson'S Disease|May 7, 2026
Practical approaches to inclusive recruitment practices in Parkinson's disease researchLana M Chahine, Naomi Louie, Elizabeth Disbrow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
BMC Neurology|October 21, 2024
The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocolLana M Chahine, Naomi Louie, J Solle, et al.
The American Journal of Clinical Nutrition|September 30, 2021
Small-quantity lipid-based nutrient supplements for children age 6-24 months: a systematic review and individual participant data meta-analysis of effects on developmental outcomes and effect modifiersElizabeth L Prado, Charles D Arnold, K Ryan Wessells, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed PopulationsMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
The Lancet. Neurology|August 26, 2023
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association studyMie Rizig, Sara Bandres-Ciga, Mary B Makarious, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populationsFulya Akçimen, Kimberly Paquette, Peter Wild Crea, et al.
Brain : a Journal of Neurology|October 8, 2025
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populationsFulya Akçimen, Kimberly Paquette, Peter Wild Crea, et al.
Pageof 15